News Conference News TCT 2013 FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients October 31, 2013
News Conference News TCT 2013 PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years October 30, 2013
News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
Presentation TCT 2013 TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:... Presenter: Byoung Kwon Lee October 29, 2013
Presentation TCT 2013 Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure Presenter: Felix Woitek October 29, 2013
News Conference News TCT 2013 State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors October 29, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013
Presentation TCT 2013 The Genesis of Local Therapy: Catheter-directed Thrombolysis Presenter: Thomas McNamara October 27, 2013
News Conference News TCT 2012 COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial November 02, 2012
News Conference News TCT 2012 Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year October 31, 2012
News Conference News TCT 2012 TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons October 26, 2012
News Conference News TCT 2012 Future Looks Bright for Stem Cell-Based Myocardial Therapy October 26, 2012
News Conference News TCT 2012 TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events October 25, 2012
News Conference News TCT 2012 Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents October 24, 2012